Cabozantinib is an oral once-daily multitarget tyrosine kinase inhibitor of MET, VEGFR2,
RET, acting against KIT, AXL, FLT3 and Tie-2. Cabozantinib has shown anti-cancer effects …

Background Anaplastic thyroid carcinoma (ATC) is the least common but most malignant
thyroid cancer. We aimed to examine the characteristics as well as evaluate the incidence …

Thyroid disorders (TD) and diabetes mellitus (DM) are the two endocrinopathies with the
highest prevalence in the general population that frequently coexist. Thyroid dysfunction is …

Purpose Thyroid cancer incidence is rising, possibly secondary to increased imaging and
surveillance. Based on rural access to care disparities, we hypothesized that incidence …

Background Disparities exist in access to high-volume surgeons, who have better outcomes
after thyroidectomy. The association of the Affordable Care Act's Medicaid expansion with …

Background Ultrasonography for thyroid nodules is one of the most common imaging tests
performed in the general population. Details from ultrasound reports guide biopsies and …

Abstract Background The American Thyroid Association (ATA) sonographic patterns stratify
the risk of malignancy of cytologically indeterminate thyroid nodules (ITNs). This study aimed …

Anaplastic thyroid cancers and radioiodine resistant thyroid cancer are posing a major treat
since surgery combined with Iodine 131 therapy is ineffective on them. Small-molecule …

The incidence of thyroid cancer has continuously increased due to its detection in the
preclinical stage. Clinical research in thyroid pathology is focusing on the development of …

The incidence of thyroid cancer has risen dramatically in the past few decades. The cause of
this is unclear, but several lines of evidence indicate it is largely due to overdiagnosis, the …